Exact Mass: 300.0401

Exact Mass Matches: 300.0401

Found 64 metabolites which its exact mass value is equals to given mass value 300.0401, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cinnavalininate

2-amino-3-oxo-3H-phenoxazine-1,9-dicarboxylic acid

C14H8N2O6 (300.0382)

Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). [HMDB] Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].

Mumefural

2-Hydroxy-1,2,3-propanetricarboxylic acid, 1-[(5-formyl-2-furanyl)methyl] ester, 9ci

C12H12O9 (300.0481)

Mumefural is isolated from fruit juice concentrate of Prunus mume (Japanese apricot Isolated from fruit juice concentrate of Prunus mume (Japanese apricot)

Indole-2-carboxylic acid, 5-(bis(2-chloroethyl)amino)-

5-[bis(2-chloroethyl)amino]-1H-indole-2-carboxylic acid

C13H14Cl2N2O2 (300.0432)

Monovanilloyltartaric acid

C12H12O9 (300.0481)

STA-0DC (TENTATIVE)

C12H12O7S (300.0304)

TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; BASE PEAK ARISES FROM CO-ELUTING COMPOUND!!!!!; Extracted (without noise removal) from ZUE_N: mz299_02_rt8_95_HCD60_STA-0DC; CONFIDENCE Tentative identification: best match only (Level 3)

Magnesium salicylate

C14H12MgO6+2 (300.0484)

3-(3-chloro-1,2-dihydroxypropyl)-8-hydroxy-6-methoxyisochromen-1-one

NCGC00381449-01!3-(3-chloro-1,2-dihydroxypropyl)-8-hydroxy-6-methoxyisochromen-1-one

C13H13ClO6 (300.0401)

Mumefural

2-Hydroxy-1,2,3-propanetricarboxylic acid, 1-[(5-formyl-2-furanyl)methyl] ester, 9ci

C12H12O9 (300.0481)

PHENOL:CHLOROFORM:ISOAMYL ALC. 25:24:1

C12H19Cl3O2 (300.0451)

Sulazepam

7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepine-2-thione

C16H13ClN2S (300.0488)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

3,5-Dinitrobenzil

C14H8N2O6 (300.0382)

Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt

C8H11N2Na3O6 (300.031)

2-phenyl-3-sulfanylidene-4,6,7,8-tetrahydrocyclopenta[2,3]thieno[2,4-b]pyrimidin-1-one

C15H12N2OS2 (300.0391)

4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID

C12H7F3N2O4 (300.0358)

tert-butyl 5-chloro-3-(chloromethyl)pyrrolo[2,3-b]pyridine-1-carboxylate

C13H14Cl2N2O2 (300.0432)

Hexyl 5-bromo-2-hydroxybenzoate

C13H17BrO3 (300.0361)

Ethyl 3-bromo-4-butoxybenzoate

C13H17BrO3 (300.0361)

A-205804

4-(p-Tolylthio)thieno[2,3-c]pyridine-2-carboxamide

C15H12N2OS2 (300.0391)

1-pyrenesulfonic acid hydrate

C16H12O4S (300.0456)

1-[(4-NITROPHENYL)SULFONYL]PYRROLIDINE-2-CARBOXYLIC ACID

C11H12N2O6S (300.0416)

1-[4-(5-bromopentoxy)-2-hydroxyphenyl]ethanone

C13H17BrO3 (300.0361)

2-(4-bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C12H15BBrFO2 (300.0332)

(2S)-1-(3-nitrophenyl)sulfonylproline

C11H12N2O6S (300.0416)

3-[2-carboxyethylsulfanyl(phenyl)methyl]sulfanylpropanoic acid

C13H16O4S2 (300.049)

1,3,5-Tris(carboxyMethoxy)benzene

C12H12O9 (300.0481)

5-(4-CHLOROPHENYL)-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE

C16H13ClN2S (300.0488)

2-Bromomethyl-4-fluorophenylboronic acid neopentyl glycol ester

C12H15BBrFO2 (300.0332)

5-Bromo-2-fluorophenylboronic acid pinacol ester

C12H15BBrFO2 (300.0332)

TERT-BUTYL (5-BROMOPYRIDIN-2-YL)(ETHYL)CARBAMATE

C12H17BrN2O2 (300.0473)

methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-methoxyphenyl)penta-2,4-dienoate

C14H14Cl2O3 (300.032)

1-benzyl-5-(4-chlorophenyl)-1H-imidazole-2-thiol

C16H13ClN2S (300.0488)

2-(1,3,4-Oxadiazol-2-yl)phenyl 4-chlorobenzenecarboxylate

C15H9ClN2O3 (300.0302)

3-chloro-N-[5-(3-pyridinyl)-1,3,4-oxadiazol-2-yl]benzamide

C14H9ClN4O2 (300.0414)

3-(3-Chloro-1,2-dihydroxypropyl)-8-hydroxy-6-methoxyisochromen-1-one

C13H13ClO6 (300.0401)

2,2-Piperazine-1,4-diylbisethanesulfonate

C8H16N2O6S2-2 (300.045)

N-acetyl-D-galactosamine 6-O-sulfate

C8H14NO9S- (300.0389)

N-acetyl-D-glucosamine 6-sulfate(1-)

C8H14NO9S- (300.0389)

N-acetyl-beta-D-galactosamine 4-O-sulfate

C8H14NO9S- (300.0389)

alpha-N-acetyl-D-glucosamine 3-sulfate

C8H14NO9S- (300.0389)

N-acetyl-beta-D-galactosamine 6-sulfate(1-)

C8H14NO9S- (300.0389)

Olsalazine(2-)

C14H8N2O6-2 (300.0382)

N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-pyridinecarboxamide

C14H9ClN4O2 (300.0414)

4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

C15H9ClN2O3 (300.0302)

5-[(6-Hydroxy-4-oxo-1-benzopyran-3-yl)methylidene]-1,3-diazinane-2,4,6-trione

C14H8N2O6 (300.0382)

4-(5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid

C15H9ClN2O3 (300.0302)

Cinnabarinic acid

C14H8N2O6 (300.0382)

Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].